Skip to main content
SpringerLink
Log in

Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

To elucidate the neuroprotective effects of the iron chelator desferrioxamine (DFO) and the antioxidant vitamin E on excessive iron-induced free radical damage, a chronic iron-loaded mice model was established. The relationship between striatal iron content, oxidized to reduced glutathione ratio, hydroxyl radical (.OH) levels and dopamine concentrations were observed in DFO or vitamin E pretreated iron-loaded/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57BL/6 mice. The results demonstrated that both DFO and vitamin E inhibit the iron accumulation and thus reverses the increase in oxidized glutathione (GSSG), oxidized to reduced glutathione ratios, .OH and lipid peroxidation levels. The striatal dopamine concentration was elevated to normal value. Our data suggested that: (1) iron may induce neuronal damage and thus excessive iron in the brain may contribute to the neuronal loss in PD; (2) iron chelators and antioxidants may serve as potential therapeutic agents in retarding the progression of neurodegeneration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Akai F, Maeda M, Hashimoto S, Taneda M, Takagi H (1995) A new animal model of cerebral infarction: magnetic embolization with carbonyl iron particles. Neurosci Lett 194: 139–141

    PubMed  Google Scholar 

  • Althaus JS, Andrus PK, Williams CM, Von Voigtlander PF, Cazers AR, Hall ED (1993) The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury: reversal by tirilazad mesylate (U-74006F). Mol Chem Neuropath 20: 147–162

    Google Scholar 

  • Andreoli SP, Cohen M (1989) Intraperitoneal desferrioxamine therapy for iron overload in children undergoing CAPD. Kidney Int 35: 1330–1335

    PubMed  Google Scholar 

  • Arendash GW, Sengstock GJ, Olanow CW, Barone S Jr, Dunn AJ (1994) Intranigral iron infusion as a model for Parkinson's disease. In: Woodruff ML, Nonneman AJ (eds) Toxin-induced models of neurological disorders. Plenum Press, New York, pp 175–212

    Google Scholar 

  • Ben-Shachar D, Youdim MBH (1991a) Intranigral iron injection induces behavioral and biochemical parkinsonism in rats. J Neurochem 57: 2133–2135

    PubMed  Google Scholar 

  • Ben-Schachar D, Eshel G, Finberg JPM, Youdim MBH (1991b) The iron chelator desferrioxamine (desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons. J Neurochem 56: 1441–1444

    PubMed  Google Scholar 

  • Ben-Schachar D, Eshel G, Riederer P, Youdim MBH (1992) Role of iron and iron chelation in dopaminergic-induced neurodegeneration: implication for PD. Ann Neurol 32: S105–111

    PubMed  Google Scholar 

  • Cadet JL, Katz M, Jackson-Lewis V, Fahn S (1989) Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence. Brain Res 476: 10–15

    PubMed  Google Scholar 

  • Ceccarelli D, Gallesi D, Giovannini F, Ferrali M, Masini A (1995) Relationship between free iron level and rat liver mitochondrial dysfunction in experimental dietary iron overload. Biochem Biophy Res Commun 209: 53–59

    Google Scholar 

  • Cohen A (1990) Current status of iron chelation therapy with desferrioxamine. Semin Hematol 27: 86–90

    PubMed  Google Scholar 

  • Cooper AJL, Pulsinelli WA, Duffy TE (1980) Glutathione and ascorbate during ischemia and postischemic reperfusion in rat brain. J Neurochem 35: 1242–1245

    PubMed  Google Scholar 

  • Crowe A, Morgan EH (1994) Effects of chelators on iron uptake and release by the brain in the rat. Neurochem Res 19: 71–76

    PubMed  Google Scholar 

  • Crowe A, Morgan EH (1996) Iron and copper interact during their uptake and deposition in the brain and other organs of developing rats exposed to dietary excess of the two metals. J Nutr 126: 183–194

    PubMed  Google Scholar 

  • Darley-Usmar VM, Hersey A, Garland LG (1989) A method for the comparative assessment of antioxidants as peroxyl radical scavengers. Biochem Pharmacol 38: 1465–1469

    PubMed  Google Scholar 

  • Denicola A, Souza JM, Gatti RM, Augusto O, Radi R (1995) Desferrioxamine inhibition of the hydroxyl radical-like reactivity of peroxynitrite: role of the hydroxamic groups. Free Radic Biol Med 19: 11–19

    PubMed  Google Scholar 

  • Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989) Increased nigral iron content and alterations in other metal ions occurring brain in Parkinson's disease. J Neurochem 52: 1830–1836

    PubMed  Google Scholar 

  • Dexter DT, Nanayakkara I, Goss-Sampson MA, Muller DPR, Harding AE, Marsden CD, Jenner P (1994) Nigral dopaminergic cell loss in vitamin E deficient rats. Neuroreport 5: 1773–1776

    PubMed  Google Scholar 

  • Erin AN, Spirin MM, Tabidze LV, Kagan VE (1984) Formation of tocopherol with fatty acids; a hypothetical mechanism of stabilization of biomembrane by vitamin E. Biochem Biophys Acta 774: 96–102

    PubMed  Google Scholar 

  • Fahn S (1992) A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease. Ann Neurol 32 [Suppl]: 128–132

    Google Scholar 

  • Floyd RA, Watson JJ, Wong PK (1984) Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products. J Biochem Biophys Methods 10: 221–235

    PubMed  Google Scholar 

  • Gerlach M, Ben-Shachar D, Riederer P, Youdim MBH (1994) Altered brain metabolism of iron as a cause of neurodegenerative disease? J Neurochem 63: 793–807

    PubMed  Google Scholar 

  • Götz ME, Künig G, Riederer P, Youdim MBH (1994) Oxidative stress: free radical production in neural degeneration. Pharmacol Ther 63: 37–122

    PubMed  Google Scholar 

  • Halliwell B (1987) Oxidants and human disease: some new concepts. FASEB J 1: 358–364

    PubMed  Google Scholar 

  • Halliwell B (1989) Protection against tissue damage in vivo by desferrioxamine: what is mechanisms of action? Free Radic Biol Med 7: 645–651

    PubMed  Google Scholar 

  • Halliwell B, Gutteridge JM (1984) Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 219: 1–14

    PubMed  Google Scholar 

  • Halliwell B, Gutteridge JM (1986) Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 246: 501–514

    PubMed  Google Scholar 

  • Hartley A, Davies M, Rice-Evans C (1990) Desferrioxamine as a lipid chain-breaking antioxidant in sickle erythrocyte membranes. FEBS Lett 264: 145–148

    PubMed  Google Scholar 

  • Ikeda Y, Ikeda K, Long DM (1989) Protective effect of the iron chelator deferoxamine on cold-induced brain edema. J Neurosurg 71: 233–238

    PubMed  Google Scholar 

  • Jenner P (1993) Altered mitochondria function, iron metabolism and glutathione levels in Parkinson's disease. Acta Neurol Scand 87 [Suppl 46]: 6–13

    Google Scholar 

  • Keberle H (1964) The biochemistry of desferrioxamine and its relation to iron metabolism. Ann NY Acad Sci 119: 758–768

    PubMed  Google Scholar 

  • Kim C, Speisky MB, Kharouba SN (1987) Rapid and sensitive method for measuring norepinephrine, dopamine, 5-hydroxytryptamine and their major metabolites in rat brain by high-performance liquid chromatography. J Chromatogr 386: 25–35

    PubMed  Google Scholar 

  • Krause GS, Kumar K, Whilt BC, Aust SD, Wiegenstein JG (1986) Ischemia, resuscitation, and reperfusion: mechanisms of tissue injury and prospects for protection. Am Heart J 111: 768–780

    PubMed  Google Scholar 

  • Lin XM, Waller SB, Dietz NJ (1995) Effects of deferoxamine and a diet deficient in vitamin E on isoelectric electroencephalographic responses associated with ischemia by the four vessel occlusion method. Life Sci 57: 989–996

    PubMed  Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275

    PubMed  Google Scholar 

  • Mizoi K, Suzuki J, Imazumi S, Yoshimoto T (1986) Development of new cerebral protective agents: the free radical scavengers. Neurol Res 8: 75–80

    PubMed  Google Scholar 

  • Odunze IN, Klaidman LK, Adams JD Jr (1990) MPTP toxicity in the mouse brain and vitamin E. Neurosci Lett 108: 346–349

    PubMed  Google Scholar 

  • Packer L, Landvik S (1990) Vitamin E in biological systems. Adv Exp Med Biol 264: 93–103

    PubMed  Google Scholar 

  • Parkinson Study Group (1989a) Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 321: 1364–1371

    Google Scholar 

  • Parkinson Study Group (1989b) DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Arch Neurol 46: 1052–1060

    Google Scholar 

  • Parkinson Study Group (1993) Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 328: 176–183

    Google Scholar 

  • Perry TL, Yong VW, Clavier RM, Jones K, Wright JM, Foulks LG, Wall RA (1985) Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse. Neurosci Lett 60: 109–114

    PubMed  Google Scholar 

  • Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52: 515–520

    PubMed  Google Scholar 

  • Saunders RD, Dugan LL, Demediuk P, Means ED, Horrocks LA, Anderson DK (1987) Effects of methylprednisolone and the combination of α-tecopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue. J Neurochem 49: 24–31

    PubMed  Google Scholar 

  • Sengstock GJ, Olanow CW, Dunn AJ, Arendash GW (1992) Iron induces degeneration of nigrostriatal neurons. Brain Res Bull 28: 645–649

    PubMed  Google Scholar 

  • Sengstock GJ, Olanow CW, Menzies RA, Dunn AJ, Arendash GW (1993) Infusion of iron into the rat substantia nigra: nigral pathology and dose dependent loss of dopaminergic markers. J Neurosci Res 35: 67–82

    PubMed  Google Scholar 

  • Sengstock GJ, Olanow CW, Dunn AJ, Barone S Jr, Arendash GW (1994) Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra. Exp Neurol 130: 82–94

    PubMed  Google Scholar 

  • Sharma BK, Bacon BR, Britton RS, Park CH, Magiera CJ, O'Neill R, Dalton N, Smanik P, Speroff T (1990) Prevention of hepatocyte injury and lipid peroxidation by iron chelators and α-tocopherol in isolated iron loaded rat hepatocytes. Hepatology 12: 31–39

    PubMed  Google Scholar 

  • Sinaceur J, Ribiere C, Nordmann J, Nordmann R (1984) Desferrioxamine: a scavenger of superoxide radicals? Biochem Pharmacol 33: 1693–1694

    PubMed  Google Scholar 

  • Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MBH (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brain. J Neurochem 56: 978–982

    PubMed  Google Scholar 

  • Soriani M, Mazzuca S, Quaresima V, Minetti M (1993) Oxidation of desferrioxamine to nitroxide free radical by activited human neutrophils. Free Radic Biol Med 14: 589–599

    PubMed  Google Scholar 

  • Spina MB, Cohen G (1989) Dopamine turnover and glutathione oxidation: implications for Parkinson's disease. Proc Natl Acad Sci USA 86: 1398–1400

    PubMed  Google Scholar 

  • Taylor E, Morgan E(1990) Developmental changes in transferrin and iron uptake by the brain in the rat. Dev Brain Res 55: 35–42

    Google Scholar 

  • Tector AJ, Olynyk JK, Britton RS, Janney CG, O'Neill R, Bacon BR (1995) Hepatic mitochondrial oxidative metabolism and lipid peroxidation in iron-loaded rats fed ethanol. J Lab Clin Med 126: 597–602

    PubMed  Google Scholar 

  • Tietze F (1969) Enzymic method for quantitative determination of nanogram amount of total and oxidized glutathione. Anal Biochem 27: 502–522

    PubMed  Google Scholar 

  • Tsukamoto H, Horne W, Kamimura S, Niemelä O, Parkkila S, Ylä-Herttuala S (1995) Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 96: 620–630

    PubMed  Google Scholar 

  • Uchiyama M, Mihara M (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86: 271–278

    PubMed  Google Scholar 

  • Uitti RJ, Rajput AH, Rozdilsky B, Bickis M, Wollin T, Yuen WK (1989) Regional metal concentrations in Parkinson's disease, other chronic neurological disease, and control brains. Can J Neurol Sci 16: 310–314

    PubMed  Google Scholar 

  • Vatassery GT, Brin MF, Fahn S, Kayden HJ, Traber MG (1988) Effect of high doses of dietary vitamin E on the concentrations of vitamin E in several brain regions, plasma, liver, and adipose tissue of rats. J Neurochem 51: 621–623

    PubMed  Google Scholar 

  • Ward RJ, Dexter D, Florence A, Aouad F, Hider R, Jenner P, Crichton R (1995) Brain iron in the ferrocene-loaded rat: its chelation and influence on dopamine metabolism. Biochem Pharmacol 49: 1821–1826

    PubMed  Google Scholar 

  • Wolfe L, Olivier N, Sallau D (1985) Prevention of cardiac disease by subcutaneous desferrioxamine in patients with thalassemia major. N Engl J Med 312: 1600–1604

    PubMed  Google Scholar 

  • Youdim MBH, Ben-Shachar D, Eshel G, Finberg JPM, Riederer P (1993) The neurotoxicity of iron and nitric oxide: relevance to the etiology of Parkinson's disease. In: Narabayashi H, Nagatsu T, Yanagisawa N, Mizuno Y (eds) Advances in neurology. Raven Press, New York, pp 259–266

    Google Scholar 

  • Zecca L, Pietra R, Goj C, Mecacci C, Radice D, Sabbioni E (1994) Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain. J Neurochem 62: 1097–1101

    PubMed  Google Scholar 

  • Zigmond MJ, Aberombie ED, Berger TW, Grace AA, Stricker EM (1990) Compensation after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 13: 290–295

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. J. Lan

    Present address: Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Füchsleinstrasse 15, D-97080, Würzburg, Germany

Authors and Affiliations

  1. Tianjin Neurological Institute, Tianjin Medical University Hospital, P. R. China

    J. Lan & D. H. Jiang

Authors
  1. J. Lan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. H. Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lan, J., Jiang, D.H. Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice. J. Neural Transmission 104, 469–481 (1997). https://doi.org/10.1007/BF01277665

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01277665

Keywords

Search

Navigation